Table 1 |
||||
|
The ALT, AST, STB and LDH levels in mouse serum after ConA administration |
||||
|
ALT |
AST |
STB |
LDH |
|
|
|
||||
|
Control group |
38.33 ± 1.53 |
85.33 ± 4.04 |
2 ± 0 |
832.67 ± 94.00 |
|
|
||||
|
1 h |
64.67 ± 7.51Δ |
194.67 ± 60.90Δ |
3.67 ± 0.58Δ |
980.0 ± 197.38 |
|
|
||||
|
3 h |
66.67 ± 12.50Δ |
222.38 ± 113.40 |
3 ± 1.00 |
2454.78 ± 198.62 |
|
|
||||
|
6 h |
1068.17 ± 418.08 |
768.0 ± 729.61Δ |
4.83 ± 0.60Δ |
3514.33 ± 977.57Δ* |
|
|
||||
|
ΔCompared with control, P < 0.05, *compared with 1 h, P < 0.05 The serum markers of liver injury, such as ALT, AST, STB and LDH, increased with time after ConA injection. Compared with normal control, ALT and STB increased at 1 h by 1.7-fold and 1.8-fold respectively, and ALT, AST, STB and LDH level at 6 h increased by 27.9-fold, 9.0-fold, 2.4-fold and 4.2-fold, respectively. |
||||
|
Chen et al. BMC Genomics 2010 11:240 doi:10.1186/1471-2164-11-240 |
||||